Multiple sclerosis (MS) is a chronic disease of the central nervous system affecting young adults. Sardinia is a high-risk area for MS. MS findings were being associated to exposure to heavy metals (Al, Cd, Cu, Fe, Mn, Pb, Zn) by in vitro studies. Aim of this study was to assess the presence of heavy metals in 51 cerebral spinal fluid (CSF) samples; 29 (56.9%) individuals were affected by MS and 22 (43.1%) subjects by other neurological disorders. Among MS patients 69% had relapsing-remitting (RR) course and 21% had a progressive. Using high resolution inductively coupled plasma mass spectrometry (ICP-MS), we determined Al, Cd, Cu, Fe, Mn, Pb, Zn CSF levels (mean+/-SD) in MS patients (2.9+/-3.58 microg/L, 0.08+/-0.06 microg/L, 18.8+/-6.5 microg/L, 35.6+/-20.8 microg/L, 1.6+/-1.4 microg/L, 0.74+/-0.39 microg/L, 74.4+/-175.7 microg/L, respectively) and in the control group ( 2.7+/-1.67 microg/L, 0.11+/-0.11 microg/L, 21.6+/-9.8 microg/L, 34.6+/-21.09 microg/L, 1.28+/-0.7 microg/L, 1+/-0.72 microg/L, 28.58+/-19.5 microg/L, respectively). Comparing to controls, Al, Mn, Zn and Fe levels were higher in MS patients; several other differences in trace element levels were also identified.

Metalli pesanti e sclerosi multipla / Sotgiu, Maria Alessandra. - (2009 Feb 11).

Metalli pesanti e sclerosi multipla

SOTGIU, Maria Alessandra
2009-02-11

Abstract

Multiple sclerosis (MS) is a chronic disease of the central nervous system affecting young adults. Sardinia is a high-risk area for MS. MS findings were being associated to exposure to heavy metals (Al, Cd, Cu, Fe, Mn, Pb, Zn) by in vitro studies. Aim of this study was to assess the presence of heavy metals in 51 cerebral spinal fluid (CSF) samples; 29 (56.9%) individuals were affected by MS and 22 (43.1%) subjects by other neurological disorders. Among MS patients 69% had relapsing-remitting (RR) course and 21% had a progressive. Using high resolution inductively coupled plasma mass spectrometry (ICP-MS), we determined Al, Cd, Cu, Fe, Mn, Pb, Zn CSF levels (mean+/-SD) in MS patients (2.9+/-3.58 microg/L, 0.08+/-0.06 microg/L, 18.8+/-6.5 microg/L, 35.6+/-20.8 microg/L, 1.6+/-1.4 microg/L, 0.74+/-0.39 microg/L, 74.4+/-175.7 microg/L, respectively) and in the control group ( 2.7+/-1.67 microg/L, 0.11+/-0.11 microg/L, 21.6+/-9.8 microg/L, 34.6+/-21.09 microg/L, 1.28+/-0.7 microg/L, 1+/-0.72 microg/L, 28.58+/-19.5 microg/L, respectively). Comparing to controls, Al, Mn, Zn and Fe levels were higher in MS patients; several other differences in trace element levels were also identified.
11-feb-2009
Metalli pesanti; sclerosi multipla; ICP-MS
Metalli pesanti e sclerosi multipla / Sotgiu, Maria Alessandra. - (2009 Feb 11).
File in questo prodotto:
File Dimensione Formato  
Sotgiu_M_Tesi_Dottorato_2009_Metalli.pdf

accesso aperto

Tipologia: Altro materiale allegato
Licenza: Non specificato
Dimensione 688.74 kB
Formato Adobe PDF
688.74 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/251213
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact